Complete 2012 forensic audit documents - Kansas Bioscience ...

As the goals of the program align with the desire of KUCC to attain the NCI designation, the
awards under this program, as well as some under the Eminent Scholar program, are being
specifically awarded to assist KUCC in achieving its goal.
The largest investment under this project is the Wahl/Hixon renovation approved in the amount
of $26.4 million in March 2009. KUCC requires space to advance its cancer research program
for NCI designation and to recruit cancer-related Eminent, Rising Star and emerging scholars.
KUCC has identified 170,000 gross square feet in the Wahl/Hixon Research Complex to meet
the near-term, state-of-the-art space needs for basic and translational cancer research. The total
estimated renovation cost is $50 million, of which $34 million is for design and construction and
$16 million is for equipment. KBA investment will support 10 years of bond payments for
construction costs.
In May 2009, the BOD authorized a budget of $600,000 to assist the advancement and support of
KUCC’s pursuit of the NCI designation. The support included hiring a project director at KBA
to work with KUCC to support comprehensive cancer care; invest in a peer review process to get
additional federal funding; retain a consulting group to provide eyes and ears in Washington
D.C. to monitor federal funding of research projects related to comprehensive cancer care; and
facilitate communication and marketing of the Comprehensive Cancer Care effort and the NCI
designation application. On July 1, 2009, KBA hired Brad Kemp as the Director of the Cancer
Cures project. Mr. Kemp serves as the liaison to KUCC.
In May 2010, the BOD authorized a budget of $693,000 to assist KUCC. The support was to
include the funding for three years of salary for a KU BioCenter Director, direct project support
and the continued retention of a consulting group.
In May 2011, the BOD authorized an additional budget of $316,000 to assist KUCC. The
support is to include direct project support and the continued retention of a consulting group.
KUCC submitted its NCI designation application in September 2011. Mr. Kemp indicated that
there is every reason to be optimistic that KUCC’s application will be successful.
As of June 30, 2011, ten Cancer Cures awards have been approved for funding in the amount of
$30,508,975. Through June 30, 2011, $10,305,123 had been paid. Please refer to Exhibit 18 for
a listing of the Cancer Cures awards.
Other Investments
Other investments, not fitting into the aforementioned categories are discussed below. Much of
the investment in this category is related to efforts to partner with other organizations to grow the
bioscience industry in Kansas, such as the investments in the annual BIO conventions discussed
in the KansasBio section later in this report.
Wichita Center for Graduate Medical Education
The largest grant in the Other Investment category is for the Wichita Center for Graduate
Medical Education (“WCGME”). WCGME is a not-for-profit consortium consisting of the KU
School of Medicine-Wichita, Via Christi Regional Medical Center and Wesley Medical Center.
WCGME employs the medical residents that work at the member hospitals and is seeking to
increase scholarly research activity by residents in response to increased requirements of the
31